CORCEPT THERAPEUTICS INC Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Corcept Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Corcept Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $47.2M, a 50.5% increase year-over-year.
  • Corcept Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $142M, a 55.2% increase year-over-year.
  • Corcept Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was $106M, a 4.66% increase from 2022.
  • Corcept Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was $101M, a 9.86% decline from 2021.
  • Corcept Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was $113M, a 6.13% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $106M +$4.72M +4.66% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $101M -$11.1M -9.86% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $113M +$6.5M +6.13% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $106M +$11.8M +12.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $94.2M +$18.8M +24.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $75.4M -$53.7M -41.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $129M +$121M +1486% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $8.14M +$14.5M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$6.41M +$25M +79.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 -$31.4M +$14.6M +31.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 -$46M -$7.96M -20.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
2012 -$38M -$5.69M -17.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 -$32.4M -$6.39M -24.6% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 -$26M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.